Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by cybermanon Nov 21, 2020 11:03pm
201 Views
Post# 31948188

RE:RE:Sorry, im new to Labs...

RE:RE:Sorry, im new to Labs...been in and out a few times, overall at a small loss but willing to take my chances at this price, and chase it down some more if i have too !

realistically we are one good PR away from a nice bounce, good luck.


lscfa wrote:

Mgmt needs to provide guidance. Analyst estimates are all over the map.....

 

 

2021 Revenue

2021 eps

no. of analysts

5

5

High

175M

$0.050

low

40.5M

($0.100)

Median 

75.6M

($0.016)

 

 


 

MissStock111 wrote:

 

Can u explain me why revenue are down so much this quarter compare to the 2019 one? Will it go back to previous revenu or is it planned to stay that low? I mean revenue of 5M and cost of sale of 15M? 

i like their fin sheet, no debt, same cash on hands... but still need to get revenu coming back...

tell me more please





<< Previous
Bullboard Posts
Next >>